Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes

Abstract

Troglitazone therapy improved metabolic control and increased body fat in patients with lipoatrophic diabetes. The substantial benefits of troglitazone must be balanced against the risk for hepatotoxicity, which can occur relatively late in the treatment course.